{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:33:24Z","timestamp":1787020404651,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Researchers in the United States have created several models to predict persons most at risk for HIV. Many of these predictive models use data from all persons newly diagnosed with HIV, the majority of whom are men, and specifically men who have sex with men (MSM). Consequently, risk factors identified by these models are biased toward features that apply only to men or capture sexual behaviours of MSM. We sought to create a predictive model for women using cohort data from two major hospitals in Chicago with large opt-out HIV screening programs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We matched 48 newly diagnosed women to 192 HIV-negative women based on number of previous encounters at University of Chicago or Rush University hospitals. We examined data for each woman for the two years prior to either their HIV diagnosis or their last encounter. We assessed risk factors including demographic characteristics and clinical diagnoses taken from patient electronic medical records (EMR) using odds ratios and 95% confidence intervals. We created a multivariable logistic regression model and measured predictive power with the area under the curve (AUC). In the multivariable model, age group, race, and ethnicity were included a priori due to increased risk for HIV among specific demographic groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The following clinical diagnoses were significant at the bivariate level and were included in the model: pregnancy (OR 1.96 (1.00, 3.84)), hepatitis C (OR 5.73 (1.24, 26.51)), substance use (OR 3.12 (1.12, 8.65)) and sexually transmitted infections (STIs) chlamydia, gonorrhoea, or syphilis. We also a priori included demographic factors that are associated with HIV. Our final model had an AUC of 0.74 and included healthcare site, age group, race, ethnicity, pregnancy, hepatitis C, substance use, and STI diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our predictive model showed acceptable discrimination between those who were and were not newly diagnosed with HIV. We identified risk factors such as recent pregnancy, recent hepatitis C diagnosis, and substance use in addition to the traditionally used recent STI diagnosis that can be incorporated by health systems to detect women who are vulnerable to HIV and would benefit from preexposure prophylaxis (PrEP).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12905-023-02460-7","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T13:01:59Z","timestamp":1686920519000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Development of a predictive model for identifying women vulnerable to HIV in Chicago"],"prefix":"10.1186","volume":"23","author":[{"given":"Eleanor E.","family":"Friedman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivanjali","family":"Shankaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha A.","family":"Devlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekta B.","family":"Kishen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly E.","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica P.","family":"Ridgway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,16]]},"reference":[{"key":"2460_CR1","unstructured":"CDC. HIV Surveillance Report, 2019 2021."},{"key":"2460_CR2","unstructured":"CDC. HIV and Women. 2022."},{"issue":"5","key":"2460_CR3","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/1552-6909.12481","volume":"43","author":"BM Brawner","year":"2014","unstructured":"Brawner BM. A multilevel understanding of HIV\/AIDS disease burden among african american women. J Obstet Gynecol Neonatal Nurs Sep-Oct. 2014;43(5):633\u201343.","journal-title":"J Obstet Gynecol Neonatal Nurs Sep-Oct"},{"issue":"1","key":"2460_CR4","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1186\/s12889-016-3364-7","volume":"17","author":"PM Frew","year":"2016","unstructured":"Frew PM, Parker K, Vo L, et al. Socioecological factors influencing women\u2019s HIV risk in the United States: qualitative findings from the women\u2019s HIV SeroIncidence study (HPTN 064). BMC Public Health Aug. 2016;17(1):803.","journal-title":"BMC Public Health Aug"},{"key":"2460_CR5","unstructured":"CDC, About. PrEP https:\/\/www.cdc.gov\/hiv\/basics\/prep\/about-prep.html. Accessed July 15, 2022."},{"issue":"6","key":"2460_CR6","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1097\/OLQ.0000000000000811","volume":"45","author":"J Raifman","year":"2018","unstructured":"Raifman J, Sherman SG. US Guidelines that Empower Women to prevent HIV with Preexposure Prophylaxis. Sex Transm Dis Jun. 2018;45(6):e38\u20139.","journal-title":"Sex Transm Dis Jun"},{"issue":"1","key":"2460_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.whi.2018.08.004","volume":"29","author":"ELP Bradley","year":"2019","unstructured":"Bradley ELP, Hoover KW. Improving HIV Preexposure Prophylaxis implementation for women: Summary of Key Findings from a discussion series with Women\u2019s HIV Prevention experts. Womens Health Issues Jan-Feb. 2019;29(1):3\u20137.","journal-title":"Womens Health Issues Jan-Feb"},{"key":"2460_CR8","doi-asserted-by":"crossref","unstructured":"Xu X, Ge Z, Chow EPF et al. A machine-learning-based risk-prediction Tool for HIV and sexually transmitted Infections Acquisition over the Next 12 months. J Clin Med Mar 25 2022;11(7).","DOI":"10.3390\/jcm11071818"},{"issue":"1","key":"2460_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12874-021-01346-2","volume":"31","author":"CK Mutai","year":"2021","unstructured":"Mutai CK, McSharry PE, Ngaruye I, Musabanganji E. Use of machine learning techniques to identify HIV predictors for screening in sub-saharan Africa. BMC Med Res Methodol Jul. 2021;31(1):159.","journal-title":"BMC Med Res Methodol Jul"},{"issue":"3","key":"2460_CR10","first-page":"153","volume":"7","author":"TG Hailu","year":"2015","unstructured":"Hailu TG. Comparing Data Mining Techniques in HIV Testing Prediction. Intell Inform Manage. 2015;7(3):153\u201380.","journal-title":"Intell Inform Manage"},{"key":"2460_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ajem.2021.09.084","volume":"51","author":"JS Haukoos","year":"2022","unstructured":"Haukoos JS, White DAE, Rowan SE, et al. Development of a 2-step algorithm to identify emergency department patients for HIV pre-exposure prophylaxis. Am J Emerg Med Jan. 2022;51:6\u201312.","journal-title":"Am J Emerg Med Jan"},{"key":"2460_CR12","doi-asserted-by":"crossref","unstructured":"Ahlstr\u00f6m MG, Ronit A, Omland LH, Vedel S, Obel N. Algorithmic prediction of HIV status using nation-wide electronic registry data. eClinicalMedicine 2019;17.","DOI":"10.1016\/j.eclinm.2019.10.016"},{"key":"2460_CR13","doi-asserted-by":"crossref","unstructured":"Tang D, Zhang M, Xu J et al. Application of Data Mining Technology on Surveillance Report Data of HIV\/AIDS High-risk group in Urumqi from 2009 to 2015. Complexity 2018\/12\/10 2018;2018:9193248.","DOI":"10.1155\/2018\/9193248"},{"issue":"5","key":"2460_CR14","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1089\/apc.2018.0011","volume":"32","author":"JP Ridgway","year":"2018","unstructured":"Ridgway JP, Almirol EA, Bender A, et al. Which patients in the Emergency Department should receive Preexposure Prophylaxis? Implementation of a Predictive Analytics Approach. AIDS Patient Care STDS May. 2018;32(5):202\u20137.","journal-title":"AIDS Patient Care STDS May"},{"issue":"1","key":"2460_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1089\/apc.2020.0231","volume":"35","author":"JP Ridgway","year":"2021","unstructured":"Ridgway JP, Friedman EE, Bender A, et al. Evaluation of an electronic algorithm for identifying Cisgender Female Pre-Exposure Prophylaxis candidates. AIDS Patient Care STDS Jan. 2021;35(1):5\u20138.","journal-title":"AIDS Patient Care STDS Jan"},{"issue":"10","key":"2460_CR16","doi-asserted-by":"publisher","first-page":"e688","DOI":"10.1016\/S2352-3018(19)30137-7","volume":"6","author":"JL Marcus","year":"2019","unstructured":"Marcus JL, Hurley LB, Krakower DS, Alexeeff S, Silverberg MJ, Volk JE. Use of electronic health record data and machine learning to identify candidates for HIV pre-exposure prophylaxis: a modelling study. Lancet HIV Oct. 2019;6(10):e688\u201395.","journal-title":"Lancet HIV Oct"},{"issue":"10","key":"2460_CR17","doi-asserted-by":"publisher","first-page":"e696","DOI":"10.1016\/S2352-3018(19)30139-0","volume":"6","author":"DS Krakower","year":"2019","unstructured":"Krakower DS, Gruber S, Hsu K, et al. Development and validation of an automated HIV prediction algorithm to identify candidates for pre-exposure prophylaxis: a modelling study. Lancet HIV Oct. 2019;6(10):e696\u2013e704.","journal-title":"Lancet HIV Oct"},{"issue":"234","key":"2460_CR18","first-page":"1","volume":"2016","author":"E Hing","year":"2012","unstructured":"Hing E, Albert M. State Variation in Preventive Care visits, by patient characteristics. NCHS Data Brief Jan. 2012;2016(234):1\u20138.","journal-title":"NCHS Data Brief Jan"},{"issue":"1","key":"2460_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/cid\/ciy441","volume":"1","author":"DK Smith","year":"2019","unstructured":"Smith DK, Chang MH, Duffus WA, Okoye S, Weissman S. Missed Opportunities to prescribe Preexposure Prophylaxis in South Carolina, 2013\u20132016. Clin Infect Dis Jan. 2019;1(1):37\u201342.","journal-title":"Clin Infect Dis Jan"},{"key":"2460_CR20","unstructured":"Long M, Frederiksen B, Ranji U, Salganicoff A. Women\u2019s Health Care Utilization and Costs: Findings from the 2020 KFF Women\u2019s Health Survey KFF 2021."},{"issue":"9","key":"2460_CR21","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1001\/jamainternmed.2014.3003","volume":"174","author":"AR Stormo","year":"2014","unstructured":"Stormo AR, Saraiya M, Hing E, Henderson JT, Sawaya GF. Women\u2019s clinical Preventive Services in the United States: who is doing what? JAMA Intern Med. 2014;174(9):1512\u20134.","journal-title":"JAMA Intern Med"},{"key":"2460_CR22","doi-asserted-by":"publisher","unstructured":"Ralph JA, Westberg SM, Boraas CM, Terrell CA, Fischer JR. PrEP-aring the General Gynecologist to offer HIV pre-exposure Prophylaxis. Clin Obstet Gynecol 9900:https:\/\/doi.org\/10.1097\/GRF.0000000000000713.","DOI":"10.1097\/GRF.0000000000000713"},{"issue":"10","key":"2460_CR23","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1089\/apc.2018.0066","volume":"32","author":"EA Almirol","year":"2018","unstructured":"Almirol EA, McNulty MC, Schmitt J, et al. Gender differences in HIV Testing, diagnosis, and linkage to Care in Healthcare Settings: identifying african American Women with HIV in Chicago. AIDS Patient Care STDS Oct. 2018;32(10):399\u2013407.","journal-title":"AIDS Patient Care STDS Oct"},{"issue":"e2","key":"2460_CR24","doi-asserted-by":"publisher","first-page":"e311","DOI":"10.1136\/amiajnl-2013-001922","volume":"20","author":"G Hripcsak","year":"2013","unstructured":"Hripcsak G, Albers DJ. Correlating electronic health record concepts with healthcare process events. J Am Med Inform Assoc Dec. 2013;20(e2):e311\u2013318.","journal-title":"J Am Med Inform Assoc Dec"},{"key":"2460_CR25","doi-asserted-by":"publisher","first-page":"k1479","DOI":"10.1136\/bmj.k1479","volume":"30","author":"D Agniel","year":"2018","unstructured":"Agniel D, Kohane IS, Weber GM. Biases in electronic health record data due to processes within the healthcare system: retrospective observational study. Bmj Apr. 2018;30:361:k1479.","journal-title":"Bmj Apr"},{"issue":"2","key":"2460_CR26","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/cid\/ciac775","volume":"13","author":"CM Burns","year":"2023","unstructured":"Burns CM, Pung L, Witt D, et al. Development of a human immunodeficiency Virus Risk Prediction Model using Electronic Health Record Data from an Academic Health System in the Southern United States. Clin Infect Dis Jan. 2023;13(2):299\u2013306.","journal-title":"Clin Infect Dis Jan"},{"issue":"1","key":"2460_CR27","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/infdis\/jiy113","volume":"5","author":"KA Thomson","year":"2018","unstructured":"Thomson KA, Hughes J, Baeten JM, et al. Increased risk of HIV Acquisition among Women throughout pregnancy and during the Postpartum period: a prospective per-coital-act analysis among women with HIV-Infected Partners. J Infect Dis Jun. 2018;5(1):16\u201325.","journal-title":"J Infect Dis Jun"},{"issue":"5","key":"2460_CR28","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1097\/QAD.0000000000002487","volume":"1","author":"LA Graybill","year":"2020","unstructured":"Graybill LA, Kasaro M, Freeborn K, et al. Incident HIV among pregnant and breast-feeding women in sub-saharan Africa: a systematic review and meta-analysis. Aids Apr. 2020;1(5):761\u201376.","journal-title":"Aids Apr"},{"issue":"4","key":"2460_CR29","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/00005792-199507000-00005","volume":"74","author":"DL Thomas","year":"1995","unstructured":"Thomas DL, Vlahov D, Solomon L, et al. Correlates of hepatitis C virus infections among injection drug users. Med (Baltimore) Jul. 1995;74(4):212\u201320.","journal-title":"Med (Baltimore) Jul"},{"issue":"1","key":"2460_CR30","doi-asserted-by":"publisher","first-page":"46","DOI":"10.2105\/AJPH.91.1.46","volume":"91","author":"J Lorvick","year":"2001","unstructured":"Lorvick J, Kral AH, Seal K, Gee L, Edlin BR. Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif. Am J Public Health Jan. 2001;91(1):46\u20137.","journal-title":"Am J Public Health Jan"},{"issue":"5","key":"2460_CR31","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/QAI.0000000000002377","volume":"15","author":"LR Hirschhorn","year":"2020","unstructured":"Hirschhorn LR, Brown RN, Friedman EE, et al. Black Cisgender Women\u2019s PrEP Knowledge, Attitudes, Preferences, and experience in Chicago. J Acquir Immune Defic Syndr Aug. 2020;15(5):497\u2013507.","journal-title":"J Acquir Immune Defic Syndr Aug"},{"issue":"4","key":"2460_CR32","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1002\/hep.23808","volume":"52","author":"RA Tohme","year":"2010","unstructured":"Tohme RA, Holmberg SD. Is sexual contact a major mode of hepatitis C virus transmission? Hepatol Oct. 2010;52(4):1497\u2013505.","journal-title":"Hepatol Oct"},{"issue":"11","key":"2460_CR33","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1089\/apc.2009.0111","volume":"23","author":"T Frederick","year":"2009","unstructured":"Frederick T, Burian P, Terrault N, et al. Factors associated with prevalent hepatitis C infection among HIV-infected women with no reported history of injection drug use: the Women\u2019s Interagency HIV Study (WIHS). AIDS Patient Care STDS Nov. 2009;23(11):915\u201323.","journal-title":"AIDS Patient Care STDS Nov"},{"issue":"11","key":"2460_CR34","doi-asserted-by":"publisher","first-page":"e13593","DOI":"10.5812\/hepatmon.13593","volume":"13","author":"A Alipour","year":"2013","unstructured":"Alipour A, Rezaianzadeh A, Hasanzadeh J, Rajaeefard A, Davarpanah MA. Sexual transmission of Hepatitis C Virus between HIV infected subjects and their main Heterosexual Partners. Hepat Mon. 2013;13(11):e13593.","journal-title":"Hepat Mon"},{"key":"2460_CR35","unstructured":"CDC. Preexposure Prophylaxis for the Prevention of HIV Infection in the United States \u2013 2021 Update Clinical Practice Guideline 2021."},{"issue":"3","key":"2460_CR36","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.1097\/AOG.0000000000002825","volume":"132","author":"ACOG. ACOG Committee Opinion No","year":"2018","unstructured":"ACOG. ACOG Committee Opinion No. 752: prenatal and Perinatal Human Immunodeficiency Virus Testing. Obstet Gynecol Sep. 2018;132(3):e138\u201342.","journal-title":"Obstet Gynecol Sep"},{"key":"2460_CR37","unstructured":"CDC, Jurisdictions. https:\/\/www.cdc.gov\/endhiv\/about.html. Accessed July 15, 2022."},{"key":"2460_CR38","unstructured":"CDC. Preexposure Prophylaxis for the Prevention of HIV Infection in the United Staes \u2013 2017 Update Clinical Practice Guideline 2017."},{"issue":"10","key":"2460_CR39","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1080\/09540121.2016.1173637","volume":"28","author":"AWB Lounsbury","year":"2016","unstructured":"Lounsbury AWB, Palma DW. Importance of substance use and violence in psychosocial syndemics among women with and at-risk for HIV. AIDS Care Oct. 2016;28(10):1316\u201320.","journal-title":"AIDS Care Oct"},{"issue":"3","key":"2460_CR40","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1007\/s11524-015-9944-5","volume":"92","author":"BA Koblin","year":"2015","unstructured":"Koblin BA, Grant S, Frye V, et al. HIV sexual risk and syndemics among women in three urban Areas in the United States: analysis from HVTN 906. J Urban Health Jun. 2015;92(3):572\u201383.","journal-title":"J Urban Health Jun"},{"key":"2460_CR41","doi-asserted-by":"publisher","first-page":"814948","DOI":"10.3389\/fcimb.2022.814948","volume":"12","author":"R Zayats","year":"2022","unstructured":"Zayats R, Murooka TT, McKinnon LR. HPV and the risk of HIV Acquisition in Women. Front Cell Infect Microbiol. 2022;12:814948.","journal-title":"Front Cell Infect Microbiol"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02460-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-023-02460-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02460-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T13:02:21Z","timestamp":1686920541000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-023-02460-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2460"],"URL":"https:\/\/doi.org\/10.1186\/s12905-023-02460-7","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,16]]},"assertion":[{"value":"6 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental protocols were approved by the ethics committee\/Institutional Review Board of the University of Chicago. The need for informed consent was waived by the ethics committee\/Institutional Review Board of the University of Chicago, because of the retrospective nature of the study (IRB20-0274-AM005).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"313"}}